TDOC - Teladoc Health Inc Stock Price, Fair Value and News

13.00USD-0.33 (-2.48%)Market Closed

Market Summary

USD13.00-0.33

Market Closed

-2.48%

TDOC Alerts

1 major insider sales recently.

TDOC Stock Price

View Fullscreen

TDOC RSI Chart

TDOC Valuation

Market Cap

2.2B

Price/Earnings (Trailing)

-9.45

Price/Sales (Trailing)

0.84

EV/EBITDA

24.36

Price/Free Cashflow

6.56

TDOC Price/Sales (Trailing)

TDOC Profitability

Operating Margin

95.09%

EBT Margin

-8.79%

Return on Equity

-10.18%

Return on Assets

-5.39%

Free Cashflow Yield

15.24%

TDOC Fundamentals

TDOC Revenue

Revenue (TTM)

2.6B

Rev. Growth (Yr)

2.68%

Rev. Growth (Qtr)

-2.18%

TDOC Earnings

Earnings (TTM)

-233.0M

Earnings Growth (Yr)

-18.29%

Earnings Growth (Qtr)

-183.45%

Breaking Down TDOC Revenue

Last 7 days

0.2%

Last 30 days

-14.9%

Last 90 days

-35.7%

Trailing 12 Months

-52.6%

How does TDOC drawdown profile look like?

TDOC Financial Health

Current Ratio

3.82

Debt/Equity

0.67

Debt/Cashflow

0.22

TDOC Investor Care

Shares Dilution (1Y)

3.29%

Diluted EPS (TTM)

-1.41

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2024	2.6B	0	0	0
2023	2.5B	2.5B	2.6B	2.6B
2022	2.1B	2.2B	2.3B	2.4B
2021	1.4B	1.6B	1.9B	2.0B
2020	605.5M	716.3M	867.1M	1.1B
2019	456.8M	492.6M	519.6M	553.3M
2018	280.0M	330.0M	372.3M	417.9M
2017	139.2M	157.3M	193.5M	233.3M
2016	87.8M	96.0M	108.4M	123.2M
2015	50.6M	58.6M	67.7M	77.4M
2014	0	27.8M	35.7M	43.5M
2013	0	0	0	19.9M

Get all data in R, Python etc through our Historical Stock Data APIs

GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224

Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index

Very Expensive Stocks

Very Cheap Stocks

Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Teladoc Health Inc

Filter Transactions

Datesorted ascending	Name	Buy/Sell	$ Value	Avg. Price	# Shares	Title
Apr 17, 2024	trencher daniel	sold	-13,210	13.21	-1,000	chief strategy officer
Apr 02, 2024	nanis nikolaos p.	sold	-6,598	14.314	-461	chief technology officer
Apr 01, 2024	nanis nikolaos p.	acquired	-	-	1,232	chief technology officer
Mar 25, 2024	geshuri arnnon	sold	-112,950	15.06	-7,500	chief people officer
Mar 25, 2024	geshuri arnnon	acquired	20,475	2.73	7,500	chief people officer
Mar 18, 2024	trencher daniel	sold	-15,180	15.18	-1,000	chief strategy officer
Mar 05, 2024	turitz andrew	sold	-82,050	14.53	-5,647	evp, corporate development
Mar 04, 2024	verstraete stephany	sold	-115,330	14.516	-7,945	chief marketing officer
Mar 04, 2024	napolitano richard j	sold	-54,652	14.516	-3,765	chief accounting officer
Mar 04, 2024	kornwasser laizer	sold	-266,354	14.516	-18,349	president, enterprise growth

Which funds bought or sold TDOC recently?

View All Details

Datesorted ascending	Fund Name	Type	% Chg	$ Change	$ Held	% Portfolio
Apr 25, 2024	Center for Financial Planning, Inc.	unchanged	-	-323	755	-%
Apr 25, 2024	Allworth Financial LP	reduced	-18.87	-10,005	13,183	-%
Apr 25, 2024	LECAP ASSET MANAGEMENT LTD	added	78.79	386,684	1,916,280	0.40%
Apr 25, 2024	Bank of New York Mellon Corp	added	4.85	-4,913,700	13,608,400	-%
Apr 25, 2024	Mendota Financial Group, LLC	unchanged	-	-148	348	-%
Apr 25, 2024	Eudaimonia Partners, LLC	unchanged	-	-95,222	222,921	0.05%
Apr 25, 2024	nVerses Capital, LLC	new	-	10,570	10,570	0.03%
Apr 25, 2024	Zurcher Kantonalbank (Zurich Cantonalbank)	added	14.34	-240,737	969,964	-%
Apr 25, 2024	Lindbrook Capital, LLC	reduced	-79.84	-9,550	1,570	-%
Apr 25, 2024	Bogart Wealth, LLC	reduced	-6.82	-988	1,857	-%

Are Funds Buying or Selling TDOC?

Are funds buying TDOC calls or puts?

Calls

Puts

No. of funds holding Calls - Puts

Net Call Options

No. of funds that own TDOC

No. of Funds

TDOC Alerts

1 major insider sales recently.

Unveiling Teladoc Health Inc's Major ShareHolders

Date Filed	Name of Filer	Percent of Class	No. of Shares	Form Type
Feb 13, 2024	nikko asset management americas, inc.	4.50%	7,464,874	SC 13G/A
Feb 13, 2024	vanguard group inc	10.58%	17,514,904	SC 13G/A
Feb 05, 2024	sumitomo mitsui trust holdings, inc.	4.51%	7,474,674	SC 13G/A
Jan 29, 2024	ark investment management llc	12.82%	21,224,565	SC 13G/A
Jan 26, 2024	blackrock inc.	8.0%	13,203,121	SC 13G/A
Jul 10, 2023	vanguard group inc	10.58%	17,313,528	SC 13G/A
Feb 10, 2023	nikko asset management americas, inc.	5.01%	8,125,231	SC 13G/A
Feb 10, 2023	ark investment management llc	11.69%	18,928,440	SC 13G/A
Feb 09, 2023	vanguard group inc	8.94%	14,476,155	SC 13G/A
Feb 07, 2023	blackrock inc.	6.2%	9,961,219	SC 13G/A

Recent SEC filings of Teladoc Health Inc

View All Filings

Date Filed	Form Type	Document
Apr 26, 2024	10-Q	Quarterly Report
Apr 25, 2024	8-K	Current Report
Apr 19, 2024	144	Notice of Insider Sale Intent
Apr 17, 2024	144	Notice of Insider Sale Intent
Apr 17, 2024	4	Insider Trading
Apr 12, 2024	8-K	Current Report
Apr 09, 2024	ARS	ARS
Apr 09, 2024	DEF 14A	DEF 14A
Apr 09, 2024	DEFA14A	DEFA14A
Apr 08, 2024	4	Insider Trading

Peers (Alternatives to Teladoc Health Inc)

Name	Mkt Capsorted ascending	Revenue	Price %, 1M	Returns, 1Y	P/E	P/S	Rev 1-Yr	Inc 1-Yr
LARGE-CAP
UNH	456.6B	371.6B	0.44%	0.97%	20.4	1.23	14.64%	11.24%
CI	103.6B	195.3B	-2.45%	41.59%	19.29	0.53	8.17%	-20.79%
CVS	84.5B	357.8B	-15.42%	-8.05%	10.12	0.24	10.95%	93.52%
HCA	81.1B	65.0B	-7.58%	8.53%	15.47	1.25	7.86%	-7.11%
CNC	39.7B	155.5B	-5.58%	8.00%	14.51	0.26	6.34%	84.42%
DVA	11.7B	12.1B	-2.44%	51.70%	16.93	0.96	4.57%	23.40%
UHS	11.5B	14.3B	-8.81%	13.72%	16.01	0.8	6.59%	6.24%
MID-CAP
CHE	8.5B	2.3B	-13.21%	2.71%	31.02	3.73	6.06%	9.17%
ACHC	6.8B	2.9B	-6.00%	1.13%	-313.66	2.32	12.20%	-107.93%
AMN	2.2B	3.8B	-7.09%	-33.84%	10.27	0.57	-27.73%	-52.50%
AMEH	2.0B	1.4B	-10.80%	1.66%	33.48	1.47	21.19%	34.42%
SMALL-CAP
ADUS	1.5B	1.1B	-8.94%	-17.15%	24.52	1.45	11.31%	35.83%
BKD	1.3B	3.0B	5.61%	63.76%	-6.97	0.44	6.74%	20.73%
BEAT	52.7M	-	-9.91%	-0.99%	-3.6	-	-	-12.94%
AMS	20.1M	21.3M	17.84%	15.27%	37.65	0.94	8.00%	-62.25%

Teladoc Health Inc News

Latest updates

Teladoc Health Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)

Income Statement (Quarterly)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Revenue	-2.2%	646,131,000	660,527,000	660,238,000	652,406,000	629,244,000	637,709,000	611,402,000	592,379,000	565,350,000	554,235,000	521,658,000	503,139,000	453,675,000	383,321,000	288,812,000	241,030,000	180,799,000	156,489,000	137,969,000	130,276,000	128,573,000
Gross Profit	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	83,896,000
Costs and Expenses	5.4%	733,253,000	695,608,000	724,963,000	724,051,000	706,346,000	4,453,262,000	683,132,000	3,688,931,000	7,234,729,000	595,664,000	582,234,000	582,087,000	538,353,000	841,827,000	308,537,000	248,209,000	201,810,000	172,077,000	157,913,000	152,299,000	151,460,000
S&GA Expenses	1.7%	54,364,000	53,451,000	52,309,000	53,530,000	54,490,000	56,279,000	54,634,000	57,930,000	58,329,000	59,330,000	62,602,000	63,856,000	64,793,000	93,942,000	23,483,000	18,687,000	17,940,000	16,751,000	16,120,000	15,832,000	16,212,000
R&D Expenses	-9.5%	81,388,000	89,938,000	84,289,000	87,309,000	86,985,000	82,931,000	84,590,000	78,696,000	87,412,000	72,867,000	80,250,000	80,759,000	78,008,000	92,697,000	29,958,000	23,029,000	19,257,000	16,246,000	15,746,000	16,665,000	15,987,000
EBITDA Margin	-8.0%	0.04	0.05	-1.42	-1.47	-2.74	-5.56	-4.10	-4.29	-3.09	-0.05	-0.37	-0.42	-	-	-	-	-	-	-	-	-
Interest Expenses	-11.0%	5,649,000	6,345,500	5,646,000	5,835,000	3,648,000	10,151,000	6,149,000	5,562,000	-5,480,000	142,634,000	-18,895,000	-20,473,000	-22,125,000	-21,100,500	-16,970,000	-13,262,000	-8,618,000	-7,581,000	-7,700,000	-7,211,000	-6,521,000
Income Taxes	-23.2%	2,700,000	3,515,000	-2,484,000	-952,000	681,000	-1,841,000	-1,171,000	-1,188,000	388,000	-49,721,500	3,643,000	3,196,000	87,000,000	-85,457,000	-2,300,000	-2,400,000	-700,000	-4,125,000	-7,300,000	100,000	742,000
Earnings Before Taxes	-212.1%	-79,199,000	-25,375,000	-59,557,000	-66,129,000	-68,547,000	-3,811,912,000	-74,647,000	-3,102,649,000	-6,674,135,000	-60,726,000	-80,697,000	-130,623,000	-112,610,000	-479,424,000	-38,174,000	-28,081,000	-30,314,000	-23,169,000	-27,644,000	-29,234,000	-29,408,000
EBT Margin	-4.2%	-0.09	-0.08	-1.55	-1.59	-2.86	-5.68	-4.27	-4.44	-3.24	-0.19	-0.43	-0.47	-	-	-	-	-	-	-	-	-
Net Income	-183.5%	-81,889,000	-28,890,000	-57,073,000	-65,177,000	-69,228,000	-3,810,071,000	-73,476,000	-3,101,461,000	-6,674,523,000	-10,985,000	-84,340,000	-133,819,000	-199,649,000	-393,967,000	-35,884,000	-25,682,000	-29,603,000	-19,044,000	-20,346,000	-29,324,000	-30,150,000
Net Income Margin	-5.1%	-0.09	-0.08	-1.55	-1.59	-2.86	-5.68	-4.24	-4.42	-3.22	-0.21	-0.44	-0.47	-	-	-	-	-	-	-	-	-
Free Cashflow	-94.0%	7,771,000	128,678,000	99,808,000	99,278,000	10,793,000	59,354,000	59,191,000	89,927,000	-35,660,000	80,285,000	75,385,000	49,927,000	-	-	-	-	-	-	-	-	-

Balance Sheet

(In Millions)

(*) denotes actual numbers (not divided by Millions)
Balance Sheet																					(In Millions)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Assets	-1.6%	4,321	4,392	4,328	4,316	4,309	4,345	8,104	8,103	11,092	17,735	17,653	17,611	17,582	17,755	3,449	2,419	1,603	1,603	1,568	1,565	1,552
Current Assets	-0.2%	1,486	1,489	1,387	1,321	1,287	1,315	1,288	1,257	1,208	1,225	1,157	1,105	1,032	1,060	1,310	1,403	596	588	558	533	541
Cash Equivalents	-2.3%	1,098	1,124	1,031	959	889	918	900	881	836	893	824	784	720	733	1,187	1,309	508	514	475	440	434
Inventory	9.3%	32.00	30.00	36.00	34.00	46.00	56.00	59.00	60.00	71.00	73.00	57.00	57.00	58.00	56.00	12.00	-	-	-	-	-	-
Net PPE	-7.7%	30.00	32.00	33.00	30.00	30.00	30.00	27.00	27.00	28.00	27.00	27.00	28.00	28.00	29.00	20.00	10.00	10.00	10.00	10.00	10.00	10.00
Goodwill	0%	1,073	1,073	1,073	1,073	1,073	1,073	4,846	4,858	7,900	14,504	14,470	14,455	14,452	14,581	1,691	900	734	746	738	748	734
Current Liabilities	-7.6%	389	421	403	383	381	400	411	371	307	331	302	276	260	333	201	124	97.00	90.00	85.00	70.00	72.00
Long Term Debt	0.1%	1,540	1,539	1,538	1,537	1,536	1,535	1,534	1,534	1,533	1,226	1,211	1,201	1,353	1,380	953	948	447	440	434	427	421
LT Debt, Current	-	-	-	-	-	-	-	-	-	-	-	-	-	-	43.00	-	-	-	-	-	-	-
LT Debt, Non Current	-100.0%	-	1,539	1,538	1,537	1,536	1,535	1,534	1,534	1,533	1,226	1,211	1,201	1,353	1,380	953	948	447	440	434	427	421
Shareholder's Equity	-1.6%	2,289	2,326	2,294	2,295	2,291	2,308	6,053	6,085	9,143	16,046	15,988	16,001	15,829	15,884	2,231	1,295	1,000	1,014	994	1,003	1,002
Retained Earnings	-0.5%	-15,310	-15,228	-15,199	-15,142	-15,077	-15,008	-11,198	-11,124	-8,023	-1,421	-1,410	-1,326	-1,192	-992	-598	-562	-537	-507	-488	-468	-438
Additional Paid-In Capital	0.3%	17,638	17,592	17,535	17,476	17,410	17,359	17,300	17,239	17,177	17,473	17,399	17,315	17,017	16,858	2,835	1,880	1,572	1,539	1,510	1,483	1,457
Shares Outstanding	1.6%	169	167	166	165	164	163	161	161	161	157	156	154	-	-	-	-	-	-	-	-	-
Float	-	-	-	-	4,145	-	-	-	5,334	-	-	-	26,317	-	-	-	14,937	-	-	-	4,607	-

Cashflow (Last 12 Months)

(In Thousands)

Cashflow (Quarterly)																					(In Thousands)
Description	(%) Q/Q	2024Q1	2023Q4	2023Q3	2023Q2	2023Q1	2022Q4	2022Q3	2022Q2	2022Q1	2021Q4	2021Q3	2021Q2	2021Q1	2020Q4	2020Q3	2020Q2	2020Q1	2019Q4	2019Q3	2019Q2	2019Q1
Cashflow From Operations	-93.1%	8,920	130,082	105,601	101,182	13,156	65,549	63,021	92,469	-31,747	83,208	76,591	52,217	-18,026	-114,936	32,195	35,550	-6,320	18,122	13,490	6,149	-7,892
Share Based Compensation	-9.6%	42,325	46,823	52,964	55,725	46,038	50,754	55,662	51,000	60,436	61,615	71,701	82,970	86,300	414,380	20,908	21,928	18,315	18,457	17,354	17,368	13,523
Cashflow From Investing	2.7%	-35,512	-36,506	-37,647	-36,570	-45,624	-53,891	-41,448	-44,837	-27,567	-20,075	-34,708	-2,168	-16,030	-413,925	-155,460	-9,662	-11,928	9,547	13,194	-5,064	7,336
Cashflow From Financing	198.6%	1,751	-1,775	5,068	4,208	3,353	4,381	634	-1,334	2,816	6,625	784	11,363	22,175	70,436	422	773,225	15,053	10,041	9,153	5,198	10,702

TDOC Income Statement

2023-12-31

Consolidated Statements of Operations and Other Comprehensive Loss - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2023	Dec. 31, 2022	Dec. 31, 2021
Income Statement [Abstract]
Revenue	$ 2,602,415	$ 2,406,840	$ 2,032,707
Expenses:
Cost of revenue (exclusive of depreciation and amortization, which are shown separately below)	760,031	743,987	650,258
Operating expenses:
Advertising and marketing	688,854	623,536	416,726
Sales	213,780	227,172	250,581
Technology and development	348,521	333,629	311,884
General and administrative	464,659	449,855	438,007
Acquisition, integration, and transformation costs	21,110	15,620	26,643
Restructuring costs	16,942	7,416	0
Depreciation	11,138	11,407	8,941
Amortization	325,933	244,620	195,298
Goodwill impairment	0	13,402,812	0
Total expenses	2,850,968	16,060,054	2,298,338
Loss from operations	(248,553)	(13,653,214)	(265,631)
Loss on extinguishment of debt	0	0	43,748
Interest income	(46,782)	(12,674)	(776)
Interest expense	22,282	21,944	81,141
Other (income) expense, net	(4,445)	859	(5,088)
Loss before provision for income taxes	(219,608)	(13,663,343)	(384,656)
Provision for income taxes	760	(3,812)	44,137
Net loss	(220,368)	(13,659,531)	(428,793)
Other comprehensive income (loss), net of tax:
Currency translation adjustment and other	5,786	(36,491)	(24,803)
Comprehensive loss	$ (214,582)	$ (13,696,022)	$ (453,596)
Net loss per share, basic (in dollars per share)	$ (1.34)	$ (84.60)	$ (2.73)
Net loss per share, diluted (in dollars per share)	$ (1.34)	$ (84.60)	$ (2.73)
Weighted-average shares used to compute basic net loss per share (in shares)	164,578,219	161,457,123	156,939,349
Weighted-average shares used to compute diluted net loss per share (in shares)	164,578,219	161,457,123	156,939,349

TDOC Balance Sheet

2023-12-31

Consolidated Balance Sheets - USD ($) $ in Thousands	Dec. 31, 2023	Dec. 31, 2022
Current assets:
Cash and cash equivalents	$ 1,123,675	$ 918,182
Accounts receivable, net of allowance for doubtful accounts of $4,240 and $4,324 at December 31, 2023 and December 31, 2022, respectively	217,423	210,554
Inventories	29,513	56,342
Prepaid expenses and other current assets	118,437	130,310
Total current assets	1,489,048	1,315,388
Property and equipment, net	32,032	29,641
Goodwill	1,073,190	1,073,190
Intangible assets, net	1,677,781	1,836,765
Operating lease - right-of-use assets	40,060	41,831
Other assets	80,258	48,540
Total assets	4,392,369	4,345,355
Current liabilities:
Accounts payable	43,637	47,690
Accrued expenses and other current liabilities	178,634	168,693
Accrued compensation	102,686	81,554
Deferred revenue-current	95,659	101,832
Total current liabilities	420,616	399,769
Other liabilities	1,080	1,618
Operating lease liabilities, net of current portion	42,837	38,042
Deferred revenue, net of current portion	13,623	11,954
Deferred taxes, net	49,452	50,939
Convertible senior notes, net	1,538,688	1,535,288
Commitments and contingencies (Note 17)
Stockholders’ equity:
Common stock, $0.001 par value; 300,000,000 shares authorized; 166,658,253 shares and 162,840,360 shares issued and outstanding as of December 31, 2023 and December 31, 2022, respectively	167	163
Additional paid-in capital	17,591,551	17,358,645
Accumulated deficit	(15,228,655)	(15,008,287)
Accumulated other comprehensive loss	(36,990)	(42,776)
Total stockholders’ equity	2,326,073	2,307,745
Total liabilities and stockholders’ equity	$ 4,392,369	$ 4,345,355

About Teladoc Health Inc

Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company operates through two segments, Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems. The BetterHelp segment operates a mental health platform that provides online counseling and therapy services through website, mobile applications, phones, and text-based interactions by its that licensed clinicians. The company offers its products and services under the Teladoc, Livongo, and BetterHelp brands. It serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. Teladoc Health, Inc. was incorporated in 2002 and is headquartered in Purchase, New York.

CEO	Mr. Jason Nathanial Gorevic
WEBSITE	teladochealth.com
INDUSTRY	Healthcare Plans
EMPLOYEES	4816

Teladoc Health Inc Frequently Asked Questions

What is the ticker symbol for Teladoc Health Inc? What does TDOC stand for in stocks?

TDOC is the stock ticker symbol of Teladoc Health Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Teladoc Health Inc (TDOC)?

As of Fri Apr 26 2024, market cap of Teladoc Health Inc is 2.17 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of TDOC stock?

You can check TDOC's fair value in chart for subscribers.

What is the fair value of TDOC stock?

You can check TDOC's fair value in chart for subscribers. The fair value of Teladoc Health Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Teladoc Health Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for TDOC so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Teladoc Health Inc a good stock to buy?

The fair value guage provides a quick view whether TDOC is over valued or under valued. Whether Teladoc Health Inc is cheap or expensive depends on the assumptions which impact Teladoc Health Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for TDOC.

What is Teladoc Health Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Fri Apr 26 2024, TDOC's PE ratio (Price to Earnings) is -9.85 and Price to Sales (PS) ratio is 0.83. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. TDOC PE ratio will change depending on the future growth rate expectations of investors.